Rafferty Asset Management
ADAP

Rafferty Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Rafferty Asset Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$369K Sell
2022
Q1 		$1.1M Sell
2021
Q4 		$2.27M Sell
2021
Q3 		$3.83M Sell
2021
Q2 		$3.49M Sell
2021
Q1 		$5.48M Buy
2020
Q4 		$803K Buy